Task: Answer the multiple-choice question.
Query: Which compound exhibits a 7.266\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCCn1c2ccccc2c2cnn(CC(=O)N3CCOCC3)c(=O)c21
b) CCOc1ccc(NC2=C(Cl)C(=O)N(C3CCCCC3)C2=O)cc1
Answer: a. CCCn1c2ccccc2c2cnn(CC(=O)N3CCOCC3)c(=O)c21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c2ccccc2c2cnn(CC(=O)N3CCOCC3)c(=O)c21
CCCn1c2ccccc2c2cnn(CC(=O)N3CCOCC3)c(=O)c21
3-(2-morpholin-4-yl-2-oxoethyl)-5-propylpyridazino[4,5-b]indol-4-one